CAI Q1 2019 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$111M+16.5% YoY

Gross Profit

$55M49.3% margin

Operating Income

$35M31.8% margin

Net Income

$19M16.7% margin

EPS (Diluted)

$0.98

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

$54M

Free Cash Flow

-$87M

Stock-Based Comp.

$839,000

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$2.2B

Stockholders' Equity

$704M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$111M	$95M	+16.5%
Gross Profit	$55M	$48M	+14.5%
Operating Income	$35M	$33M	+8.5%
Net Income	$19M	$17M	+8.4%